Eledon Pharmaceuticals, Inc. · NASDAQ:ELDN
Vanguard Capital Management LLC reported a 5.05% stake in Eledon Pharmaceuticals, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 31, 2026
Vanguard Capital Management LLC reported a 5.05% stake in Eledon Pharmaceuticals, Inc., 3,898,446 shares, as a passive investor on Jun 30, 2026. Filed Jul 31, 2026 (Schedule 13G).
- Stake
- 5.05%
- Shares
- 3,898,446
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.05% | 3,898,446 |
Source
Related
- Eledon Pharmaceuticals, Inc.
- Vanguard Capital Management LLC
- Eledon Pharmaceuticals, Inc. shareholders
- Form 4 · Gros David-Alexandre C · Aug 4, 2026
- Form 4 · Perrin Steven · Aug 4, 2026
- Schedule 13G/A · Bvf Partners L P · May 15, 2026
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026